Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.
WHO Calls For Caution When it Comes to Using AI For Health
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals
Rules & Regulations on Cosmetic Procedures: Where Are They?
Getting Started With Practice Tech: Pearls From Brandon Beal, MD
APPs May Fill in Gaps Due to Growing Shortages of Physicians, Nurses
2 Clarke Drive Cranbury, NJ 08512